Chronic inflammatory demyelinating polyneuritis
ICD-10 G61.81 is a billable code used to indicate a diagnosis of chronic inflammatory demyelinating polyneuritis.
Chronic inflammatory demyelinating polyneuritis (CIDP) is a neurological disorder characterized by progressive weakness and sensory loss due to the immune-mediated damage of peripheral nerves. It is classified as a type of autoimmune neuropathy, where the body's immune system mistakenly attacks the myelin sheath that insulates nerve fibers, leading to demyelination. Patients typically present with symptoms such as muscle weakness, numbness, tingling, and loss of reflexes, which can vary in severity and may affect both proximal and distal muscles. CIDP can be diagnosed through a combination of clinical evaluation, electrodiagnostic studies, and nerve biopsies. Electrodiagnostic studies, including nerve conduction studies (NCS) and electromyography (EMG), are crucial for assessing the extent of nerve damage and demyelination. The condition may be chronic, with symptoms persisting for months or years, and can lead to significant disability if not treated. Treatment options include corticosteroids, immunoglobulin therapy, and plasmapheresis, aimed at reducing inflammation and improving nerve function.
Detailed neurological examination findings, results of electrodiagnostic studies, and treatment plans.
Patients presenting with progressive weakness, sensory disturbances, and reflex changes.
Ensure comprehensive documentation of symptom onset, duration, and response to treatment.
Functional assessments, treatment goals, and progress notes.
Rehabilitation needs for patients with CIDP-related disabilities.
Document functional limitations and rehabilitation interventions clearly.
Used to confirm diagnosis of CIDP through assessment of nerve conduction velocities.
Document the specific nerves tested and results.
Neurologists should ensure comprehensive reporting of findings.
Common symptoms include progressive weakness, sensory loss, numbness, tingling, and loss of reflexes, which can vary in severity.
CIDP is diagnosed through clinical evaluation, electrodiagnostic studies, and sometimes nerve biopsies to assess the extent of nerve damage.
Treatment options include corticosteroids, immunoglobulin therapy, and plasmapheresis, aimed at reducing inflammation and improving nerve function.
